# EDGAR Filing Document

**Accession Number:** 0001490054
**File Stem:** 0001096906-23-000575
**Filing Date:** 2023-3
**Character Count:** 5541
**Document Hash:** a76e64dafe8a45b8cc2de297813901cb
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001096906-23-000575.hdr.sgml**: 20230320

**ACCESSION NUMBER**: 0001096906-23-000575

**CONFORMED SUBMISSION TYPE**: NT 10-Q

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230131

**FILED AS OF DATE**: 20230320

**DATE AS OF CHANGE**: 20230317

**EFFECTIVENESS DATE**: 20230320

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** VERDE BIO HOLDINGS, INC.
- **CENTRAL INDEX KEY:** 0001490054
- **STANDARD INDUSTRIAL CLASSIFICATION:** CRUDE PETROLEUM & NATURAL GAS [1311]
- **IRS NUMBER:** 300678378
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0430

**FILING VALUES:**
- **FORM TYPE:** NT 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-54524
- **FILM NUMBER:** 23744352

**BUSINESS ADDRESS:**
- **STREET 1:** 5 COWBOYS WAY
- **STREET 2:** SUITE 300
- **CITY:** FRISCO
- **STATE:** TX
- **ZIP:** 75034
- **BUSINESS PHONE:** (205) 864-5377

**MAIL ADDRESS:**
- **STREET 1:** 5 COWBOYS WAY
- **STREET 2:** SUITE 300
- **CITY:** FRISCO
- **STATE:** TX
- **ZIP:** 75034

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** APPIPHANY TECHNOLOGIES HOLDINGS CORP
- **DATE OF NAME CHANGE:** 20100421

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 12b-25**

**NOTIFICATION OF LATE FILING**

SEC File Number: 000-54525

(Check one):&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

[ ] Form 10-K

[ ] Form 20-F

[ ] Form 11-K

[X] Form 10-Q

[ ] Form N-SAR

For Period Ended: **January 31, 2023**

[ ]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transition Report on Form 10-K

[ ]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transition Report on Form 20-F

[ ]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transition Report on Form 11-K

[ ]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transition Report on Form 10-Q

[ ]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transition Report on Form N-SAR

For the Transition Period Ended: _______________

If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:

**PART I - REGISTRANT INFORMATION**

12b-25

---

| |
|:---|
| **Verde Bio Holdings, Inc.** |
| **Full Name of Registrant** |

---

---

| |
|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;**N/A** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Former Name if Applicable** |
| &nbsp;&nbsp;&nbsp;&nbsp;**5750 Genesis Court, Suite 220B** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Address of Principal Executive Office *(Street and Number)*** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Frisco, Texas 75043** |
| &nbsp;&nbsp;&nbsp;&nbsp;**City, State and Zip Code** |

---

------

**PART II - RULES 12b-25(b) AND (c)**

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

(a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

---

| | | |
|:---|:---|:---|
| [ **X** ] | (b) | The subject annual report, semi-annual report, transition report on Forms 10-K, 20-F, 11-K, Form N-SAR, or portion thereof, will be filed on or before the 15th calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and |

---

(c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been <br> attached if applicable.

**PART III - NARRATIVE**

State below in reasonable detail the reasons why Forms 10-K, 11-K, 20-F, 10-Q, N-SAR, or the transition report portion thereof, could not be filed within the prescribed time period.

There will be a delay in filing the Company's Quarterly Report on Form 10-Q for the year ending July 31, 2021 because the Company's accountants needs additional time to complete the financial statements as required by the auditors and the auditors need additional time to review the Company's financial statements once revised.

**PART IV - OTHER INFORMATION**

(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Name and telephone number of person to contact in regard to this notification:

---

| | |
|:---|:---|
| **Scott Cox** | **(972) 217-4080** |
| (Name) | (Area Code) (Telephone number) |

---

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months (or for such shorter) period that the registrant was required to file such reports) been filed? If answer is no, identify report(s):[ **X** ] Yes[ ] No

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof: [ ] Yes [ **X** ] No

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

**Verde Bio Holdings, Inc.**

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

---

| |
|:---|
| Date: March 17, 2023 |
| /s/ Scott Cox |
| By: Scott Cox |
| Its: Chief Executive Officer |

---